According to Pharmabiz, the studies involved the application of Malvern’s light scattering technologies in evaluating the formulation stability of Albucult and Recombumin.
The teams applied the resolving capabilities of size exclusion chromatography light scattering and dynamic light scattering offered by Malvern’s Zetasizer Nano system to monitor the stability of Novozymes products.
Novozymes customer solution specialist Mark Perkins said that the Malvern systems have proved highly effective in this application, allowing the company to further demonstrate the stability and purity of its products.